GM9
2-[3-[[(4-~{tert}-butylphenyl)methyl-pyridin-3-ylsulfonyl-amino]methyl]phenoxy]ethanoic acid
Find entries where: GM9
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
|---|---|
| Name | 2-[3-[[(4-~{tert}-butylphenyl)methyl-pyridin-3-ylsulfonyl-amino]methyl]phenoxy]ethanoic acid |
| Identifiers | 2-[3-[[(4-~{tert}-butylphenyl)methyl-pyridin-3-ylsulfonyl-amino]methyl]phenoxy]ethanoic acid |
| Formula | C25 H28 N2 O5 S |
| Molecular Weight | 468.565 |
| Type | NON-POLYMER |
| Isomeric SMILES | CC(C)(C)c1ccc(cc1)CN(Cc2cccc(c2)OCC(=O)O)S(=O)(=O)c3cccnc3 |
| InChI | InChI=1S/C25H28N2O5S/c1-25(2,3)21-11-9-19(10-12-21)16-27(33(30,31)23-8-5-13-26-15-23)17-20-6-4-7-22(14-20)32-18-24(28)29/h4-15H,16-18H2,1-3H3,(H,28,29) |
| InChIKey | WOHRHWDYFNWPNG-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 61 |
| Chiral Atom Count | 0 |
| Bond Count | 63 |
| Aromatic Bond Count | 18 |
Drug Info: DrugBank
| DrugBank ID | DB12022 |
|---|---|
| Name | Evatanepag |
| Groups | investigational |
| Description | Evatanepag has been used in trials studying the treatment of Tibial Fractures. |
| Synonyms |
|
| CAS number | 223488-57-1 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL563646 |
| PubChem | 9890801 |
| ChEMBL | CHEMBL563646 |
